Diversify Wealth Management’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Diversify Wealth Management's BMY Position: Q2 2026 in Review
Diversify Wealth Management increased its Bristol-Myers Squibb (BMY) stake by 12% in Q2 2026, buying an estimated $235K and bringing the position to 37,231 shares worth $2.33M. The position accounts for 0.04% of the portfolio, ranked #358.
Diversify Wealth Management first reported a position in BMY in Q2 2024 and has held it in 9 quarters since. 2,529 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Diversify Wealth Management held 37,231 shares of Bristol-Myers Squibb worth $2.33M as of Q2 2026.
- Diversify Wealth Management bought 4,092 Bristol-Myers Squibb shares in Q2 2026, an estimated $235K.
- Bristol-Myers Squibb made up 0.04% of Diversify Wealth Management's portfolio in Q2 2026, its #358 holding.
- Diversify Wealth Management first reported a position in Bristol-Myers Squibb in Q2 2024 and has held it in 9 quarters since.
- 2,529 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Diversify Wealth Management's 13F filing for Q2 2026, filed 30 Jul 2026.